MedLumics
PrivateLast Round
VC Round
Jul 29, 2024
Total Funding Raised
$66.11M
Company Overview
MedLumics is a medical device company developing AblaView, an optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedLumics Comparables
Compare MedLumics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CardioFocus | 85% | |
| ElectroPhysiology Frontiers S.p.A. | 83% | |
| Kardium | 80% |
MedLumics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 29, 2024 | ||||
| VC Round | Feb 13, 2024 | ||||
| Series E | Feb 10, 2021 | ||||
| Grant | May 1, 2019 | ||||
| Series B | Mar 20, 2017 | ||||
Series A | Dec 1, 2011 |
MedLumics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | VC Round, Series E |
| CDTI Innvierte | Series E |
| Seroba Life Sciences | Series B |
| Andera Partners | Series E, Series B |
| European Commission | Grant |
| Ysios Capital | Series B, Series A |
| Innogest Capital | Series B, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2021
$22M round led by Asabys Partners and VI Partners.
- May 1, 2019
$2.76M grant from the European Commission
MedLumics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MedLumics's valuation, stock price, and market status.
Is MedLumics a public or private company?
MedLumics is a private company.
What is the current stock price of MedLumics?
MedLumics is a private company, so its shares have no public market price. Caplight tracks MedLumics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MedLumics worth (valuation)?
Valuation information for MedLumics is not publicly available.
Can I buy MedLumics stock?
MedLumics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MedLumics's last funding round?
MedLumics's most recent funding round was VC Round on July 29, 2024.
Who are the main investors in MedLumics?
Key investors in MedLumics include Asabys Partners, Andera Partners, Ysios Capital, VI Partners, Criteria Capital Risc.
Will MedLumics IPO soon?
No public IPO plans have been announced for MedLumics.
How can I track MedLumics secondary market activity?
Caplight tracks bids, offers, and trades in MedLumics's shares on secondary markets.